RELMADA THERAPEUTICS, INC. Operating Cash Flow
RELMADA THERAPEUTICS, INC. (RLMD) reported Operating Cash Flow of -$24.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.61M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$15.07M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$14.60M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$6.72M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$45.79M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$51.76M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$51.66M.
- RELMADA THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$103.80M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 21 month | Net Cash Provided by (Used in) Operating Activities 24 month | Net Cash Provided by (Used in) Operating Activities 27 month | Net Cash Provided by (Used in) Operating Activities 30 month | Net Cash Provided by (Used in) Operating Activities 33 month | Net Cash Provided by (Used in) Operating Activities 115 month | Net Cash Provided by (Used in) Operating Activities 118 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$24.67M 10-Q · filed 2026-08-06 | -$39.27M derived: sum of 3 quarters · filed 2026-08-06 | -$45.99M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2026-03-31 | -$15.07M 10-Q · filed 2026-05-12 | -$29.66M derived: sum of 2 quarters · filed 2026-05-12 | -$36.39M derived: sum of 3 quarters · filed 2026-05-12 | -$42.79M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-12-31 | -$14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$21.32M derived: sum of 2 quarters · filed 2026-03-19 | -$27.72M derived: sum of 3 quarters · filed 2026-08-06 | -$45.79M 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | -$6.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$13.12M derived: sum of 2 quarters · filed 2026-08-06 | -$31.19M 10-Q · filed 2025-11-13 | -$39.99M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-06-30 | -$6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$24.47M 10-Q · filed 2026-08-06 | -$33.27M derived: sum of 3 quarters · filed 2026-08-06 | -$49.92M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-03-31 | -$18.07M 10-Q · filed 2026-05-12 | -$26.87M derived: sum of 2 quarters · filed 2026-05-12 | -$43.52M derived: sum of 3 quarters · filed 2026-05-12 | -$56.79M derived: sum of 4 quarters · filed 2026-05-12 | |||||||
| 2024-12-31 | -$8.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$25.46M derived: sum of 2 quarters · filed 2026-03-19 | -$38.72M derived: sum of 3 quarters · filed 2026-03-19 | -$51.76M 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | -$16.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$29.92M derived: sum of 2 quarters · filed 2025-11-13 | -$42.96M 10-Q · filed 2025-11-13 | -$53.21M derived: sum of 4 quarters · filed 2025-11-13 | |||||||
| 2024-06-30 | -$13.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$26.30M 10-Q · filed 2025-08-07 | -$36.55M derived: sum of 3 quarters · filed 2025-08-07 | -$48.18M derived: sum of 4 quarters · filed 2025-08-07 | |||||||
| 2024-03-31 | -$13.04M 10-Q · filed 2025-05-12 | -$23.29M derived: sum of 2 quarters · filed 2025-05-12 | -$34.92M derived: sum of 3 quarters · filed 2025-05-12 | -$48.19M derived: sum of 4 quarters · filed 2025-05-12 | |||||||
| 2023-12-31 | -$10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$21.88M derived: sum of 2 quarters · filed 2025-03-27 | -$35.15M derived: sum of 3 quarters · filed 2025-03-27 | -$51.66M 10-K · filed 2025-03-27 | |||||||
| 2023-09-30 | -$11.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$24.90M derived: sum of 2 quarters · filed 2024-11-07 | -$41.41M 10-Q · filed 2024-11-07 | -$77.29M derived: sum of 4 quarters · filed 2024-11-07 | |||||||
| 2023-06-30 | -$13.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$29.78M 10-Q · filed 2024-08-07 | -$65.66M derived: sum of 3 quarters · filed 2024-08-07 | -$92.52M derived: sum of 4 quarters · filed 2024-08-07 | |||||||
| 2023-03-31 | -$16.51M 10-Q · filed 2024-05-08 | -$52.39M derived: sum of 2 quarters · filed 2024-05-08 | -$79.25M derived: sum of 3 quarters · filed 2024-05-08 | -$100.88M derived: sum of 4 quarters · filed 2024-05-08 | |||||||
| 2022-12-31 | -$35.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$62.75M derived: sum of 2 quarters · filed 2024-03-19 | -$84.37M derived: sum of 3 quarters · filed 2024-03-19 | -$103.80M 10-K · filed 2024-03-19 | |||||||
| 2022-09-30 | -$26.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$48.49M derived: sum of 2 quarters · filed 2023-11-08 | -$67.92M 10-Q · filed 2023-11-08 | -$105.58M derived: sum of 4 quarters · filed 2023-11-08 | |||||||
| 2022-06-30 | -$21.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$41.06M 10-Q · filed 2023-08-08 | -$78.72M derived: sum of 3 quarters · filed 2023-08-08 | -$99.63M derived: sum of 4 quarters · filed 2023-08-08 | |||||||
| 2022-03-31 | -$19.43M 10-Q · filed 2023-05-11 | -$57.09M derived: sum of 2 quarters · filed 2023-05-11 | -$78.01M derived: sum of 3 quarters · filed 2023-05-11 | -$95.22M derived: sum of 4 quarters · filed 2023-05-11 | |||||||
| 2021-12-31 | -$37.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$58.58M derived: sum of 2 quarters · filed 2023-03-23 | -$75.79M derived: sum of 3 quarters · filed 2023-03-23 | -$91.87M 10-K · filed 2023-03-23 | |||||||
| 2021-09-30 | -$20.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$38.13M derived: sum of 2 quarters · filed 2022-11-10 | -$54.21M 10-Q · filed 2022-11-10 | -$61.14M derived: sum of 4 quarters · filed 2022-11-10 | |||||||
| 2021-06-30 | -$17.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$33.30M 10-Q · filed 2022-08-11 | -$40.23M derived: sum of 3 quarters · filed 2022-08-11 | -$52.73M derived: sum of 4 quarters · filed 2022-08-11 | |||||||
| 2021-03-31 | -$16.09M 10-Q · filed 2022-05-05 | -$23.01M derived: sum of 2 quarters · filed 2022-05-05 | -$35.52M derived: sum of 3 quarters · filed 2022-05-05 | -$40.47M derived: sum of 4 quarters · filed 2022-05-05 | |||||||
| 2020-12-31 | -$6.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$19.43M derived: sum of 2 quarters · filed 2022-03-25 | -$24.38M derived: sum of 3 quarters · filed 2022-03-25 | -$27.81M 10-K · filed 2022-03-25 | |||||||
| 2020-09-30 | -$12.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$17.46M derived: sum of 2 quarters · filed 2021-11-12 | -$20.88M 10-Q · filed 2021-11-12 | -$24.76M derived: sum of 4 quarters · filed 2021-11-12 | |||||||
| 2020-06-30 | -$4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$8.38M 10-Q · filed 2021-08-10 | -$12.26M derived: sum of 3 quarters · filed 2021-08-10 | -$14.79M derived: sum of 4 quarters · filed 2021-08-10 | |||||||
| 2020-03-31 | -$3.42M 10-Q · filed 2021-05-12 | -$7.30M derived: sum of 2 quarters · filed 2021-05-12 | -$9.84M derived: sum of 3 quarters · filed 2021-05-12 | -$13.51M derived: sum of 4 quarters · filed 2021-05-12 | |||||||
| 2019-12-31 | -$3.88M derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24 | -$6.41M 10-K · filed 2021-03-24 | -$10.08M derived: sum of 3 quarters · filed 2021-03-24 | -$12.09M 10-K · filed 2021-03-24 | |||||||
| 2019-09-30 | -$2.53M 10-Q · filed 2019-11-13 | -$6.20M derived: sum of 2 quarters · filed 2020-08-12 | -$8.21M 10-Q · filed 2020-11-12 | -$11.36M derived: sum of 4 quarters · filed 2020-08-12 | |||||||
| 2019-06-30 | -$3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$5.68M 10-Q · filed 2020-08-12 | -$8.83M derived: sum of 3 quarters · filed 2020-08-12 | -$10.50M 10-K · filed 2021-03-24 | |||||||
| 2019-03-31 | -$2.01M 10-Q · filed 2020-05-15 | -$5.16M derived: sum of 2 quarters · filed 2020-05-15 | -$6.83M 10-Q · filed 2019-05-15 | -$9.10M derived: sum of 4 quarters · filed 2020-05-15 | |||||||
| 2018-12-31 | -$3.15M derived: 10-KT 6 month − 10-Q 3 month · filed 2020-03-26 | -$4.82M 10-KT · filed 2020-03-26 | -$7.09M derived: sum of 3 quarters · filed 2020-03-26 | -$8.71M derived: sum of 4 quarters · filed 2020-03-26 | |||||||
| 2018-09-30 | -$1.67M 10-Q · filed 2019-11-13 | -$3.94M derived: sum of 2 quarters · filed 2020-03-26 | -$5.56M derived: sum of 3 quarters · filed 2020-03-26 | -$6.69M derived: sum of 4 quarters · filed 2020-03-26 | |||||||
| 2018-06-30 | -$2.27M derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26 | -$3.89M derived: sum of 2 quarters · filed 2020-03-26 | -$5.02M derived: sum of 3 quarters · filed 2020-03-26 | -$6.00M 10-KT · filed 2020-03-26 | |||||||
| 2018-03-31 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | -$2.76M derived: sum of 2 quarters · filed 2019-05-15 | -$3.74M 10-Q · filed 2019-05-15 | -$4.75M derived: sum of 4 quarters · filed 2019-05-15 | |||||||
| 2017-12-31 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | -$2.11M 10-Q · filed 2019-02-13 | -$3.13M derived: sum of 3 quarters · filed 2019-02-13 | -$4.98M derived: sum of 4 quarters · filed 2019-02-13 | |||||||
| 2017-09-30 | -$979.05K 10-Q · filed 2018-11-13 | -$2.00M derived: sum of 2 quarters · filed 2018-11-13 | -$3.85M derived: sum of 3 quarters · filed 2018-11-13 | -$5.30M derived: sum of 4 quarters · filed 2018-11-13 | |||||||
| 2017-06-30 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28 | -$2.87M derived: sum of 2 quarters · filed 2018-09-28 | -$4.32M derived: sum of 3 quarters · filed 2018-09-28 | -$6.47M 10-K · filed 2018-09-28 | |||||||
| 2017-03-31 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | -$3.31M derived: sum of 2 quarters · filed 2018-05-14 | -$5.45M 10-Q · filed 2018-05-14 | -$8.28M derived: sum of 4 quarters · filed 2018-05-14 | |||||||
| 2016-12-31 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | -$3.60M 10-Q · filed 2018-02-12 | -$6.42M derived: sum of 3 quarters · filed 2018-02-12 | -$10.05M derived: sum of 4 quarters · filed 2018-02-12 | |||||||
| 2016-09-30 | -$2.14M 10-Q · filed 2016-11-10 | -$4.97M derived: sum of 2 quarters · filed 2017-09-28 | -$8.60M derived: sum of 3 quarters · filed 2017-09-28 | -$12.07M derived: sum of 4 quarters · filed 2017-09-28 | |||||||
| 2016-06-30 | -$2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$6.45M derived: sum of 2 quarters · filed 2017-09-28 | -$9.93M derived: sum of 3 quarters · filed 2017-09-28 | -$13.14M 10-K · filed 2017-09-28 | |||||||
| 2016-03-31 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$7.10M derived: sum of 2 quarters · filed 2017-05-15 | -$10.32M 10-Q · filed 2017-05-15 | -$14.81M derived: sum of 4 quarters · filed 2017-05-15 | |||||||
| 2015-12-31 | -$3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$6.69M 10-Q · filed 2017-02-10 | -$11.18M derived: sum of 3 quarters · filed 2017-02-10 | -$15.61M derived: sum of 4 quarters · filed 2017-02-10 | |||||||
| 2015-09-30 | -$3.22M 10-Q · filed 2016-11-10 | -$7.70M derived: sum of 2 quarters · filed 2016-11-10 | -$12.14M derived: sum of 3 quarters · filed 2016-11-10 | -$17.12M derived: sum of 4 quarters · filed 2016-11-10 | |||||||
| 2015-06-30 | -$4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | -$8.92M derived: sum of 2 quarters · filed 2016-09-09 | -$13.90M derived: sum of 3 quarters · filed 2016-09-09 | -$16.23M 10-K · filed 2016-09-09 | |||||||
| 2015-03-31 | -$4.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -$9.42M derived: sum of 2 quarters · filed 2016-05-09 | -$11.74M 10-Q · filed 2016-05-09 | -$12.88M derived: sum of 4 quarters · filed 2016-05-09 | |||||||
| 2014-12-31 | -$4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05 | -$7.31M 10-Q · filed 2016-02-05 | -$8.45M derived: sum of 3 quarters · filed 2016-02-05 | -$9.47M derived: sum of 4 quarters · filed 2016-02-05 | |||||||
| 2014-09-30 | -$2.32M 10-Q · filed 2015-11-06 | -$3.47M derived: sum of 2 quarters · filed 2015-11-06 | -$4.49M derived: sum of 3 quarters · filed 2015-11-06 | ||||||||
| 2014-06-30 | -$1.15M derived: 10-K 6 month − 8-K 3 month · filed 2015-09-11 | -$2.16M 10-K · filed 2015-09-11 | |||||||||
| 2014-03-31 | -$1.02M 8-K · filed 2014-05-27 | -$1.85M 10-Q · filed 2015-05-15 | -$10.82M 8-K · filed 2014-05-27 | ||||||||
| 2014-02-28 | -$3.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-15 | -$12.66K 10-Q · filed 2014-04-15 | -$39.07K 10-Q · filed 2014-04-15 | ||||||||
| 2013-12-31 | -$420.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-13 | -$829.28K 10-Q · filed 2015-02-13 | -$2.24M 10-K · filed 2015-09-11 | -$9.80M 8-K · filed 2014-05-27 | |||||||
| 2013-11-30 | -$9.12K 10-Q · filed 2014-01-13 | -$35.53K 10-Q · filed 2014-01-13 | |||||||||
| 2013-09-30 | -$408.70K 10-Q · filed 2014-11-07 | ||||||||||
| 2013-08-31 | -$5.37K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | -$10.41K derived: sum of 2 quarters · filed 2013-12-16 | -$11.86K 10-K · filed 2013-12-16 | -$26.41K 10-K · filed 2013-12-16 | |||||||
| 2013-05-31 | -$5.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-12 | -$6.49K 10-Q · filed 2013-07-12 | -$21.04K 10-Q · filed 2013-07-12 | ||||||||
| 2013-03-31 | -$399.88K 8-K · filed 2014-05-27 | ||||||||||
| 2013-02-28 | -$2.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-15 | -$1.45K 10-Q · filed 2014-04-15 | -$4.79K derived: sum of 3 quarters · filed 2014-04-15 | -$6.78K derived: sum of 4 quarters · filed 2014-04-15 | -$16.00K 10-Q · filed 2013-05-03 | ||||||
| 2012-12-31 | -$1.58M 10-KT · filed 2014-09-09 | ||||||||||
| 2012-11-30 | $1.50K 10-Q · filed 2014-01-13 | -$1.85K derived: sum of 2 quarters · filed 2014-01-13 | -$3.83K derived: sum of 3 quarters · filed 2014-01-13 | ||||||||
| 2012-08-31 | -$3.34K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | -$5.33K derived: sum of 2 quarters · filed 2013-12-16 | -$7.57K 10-K · filed 2013-12-16 | ||||||||
| 2012-05-31 | -$1.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-12 | -$4.22K 10-Q · filed 2013-07-12 | |||||||||
| 2012-02-29 | -$2.23K 10-Q · filed 2013-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |